Cholestech, Roche Settle on Cholesterol Kit

Law360, New York (December 30, 2003, 12:00 AM EST) -- Cholestech Corp., a California-based maker of blood testing products, said it would pay $7 million to Roche Diagnostics Corp. as part of a licensing agreement to settle litigation over patents related to measuring HDL cholesterol.

As part of the settlement, Roche will grant Cholestech an irrevocable, non-exclusive, worldwide license for its patents related to HDL cholesterol. Cholestech will pay Roche an ongoing royalty that will be applied to only the HDL portion of cholesterol test cassettes sold by Cholestech.

Roche sued Cholestech in the U.S. District...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.